Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Challenges and perspectives in the treatment of diabetes associated breast cancer
Samson Mathews Samuel, Elizabeth Varghese, Sharon Varghese, et al.
Cancer Treatment Reviews (2018) Vol. 70, pp. 98-111
Open Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan
Ibrahim Mohammed, Morley D. Hollenberg, Hong Ding, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 194
Obesity, Diabetes, and Increased Cancer Progression
Dae-Seok Kim, Philipp E. Scherer
Diabetes & Metabolism Journal (2021) Vol. 45, Iss. 6, pp. 799-812
Open Access | Times Cited: 165
Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer
Elizabeth Varghese, Samson Mathews Samuel, Alena Líšková, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2252-2252
Open Access | Times Cited: 161
The obesity-breast cancer link: a multidisciplinary perspective
Emily Devericks, Meredith S. Carson, Lauren E. McCullough, et al.
Cancer and Metastasis Reviews (2022) Vol. 41, Iss. 3, pp. 607-625
Open Access | Times Cited: 72
Hyperglycemia Associated Metabolic and Molecular Alterations in Cancer Risk, Progression, Treatment, and Mortality
Pranay Ramteke, Ankita Deb, Varsha Shepal, et al.
Cancers (2019) Vol. 11, Iss. 9, pp. 1402-1402
Open Access | Times Cited: 124
Anti-Cancer Agents in Proliferation and Cell Death: The Calcium Connection
Elizabeth Varghese, Samson Mathews Samuel, Zuhair Sadiq, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 12, pp. 3017-3017
Open Access | Times Cited: 114
The Role of Adipokines in Breast Cancer: Current Evidence and Perspectives
Gerasimos Socrates Christodoulatos, Nikolaos Spyrou, Jona Kadillari, et al.
Current Obesity Reports (2019) Vol. 8, Iss. 4, pp. 413-433
Closed Access | Times Cited: 82
Metformin and Breast Cancer: Where Are We Now?
Mónica Cejuela Solís, Begoña Martı́n-Castillo, Javier A. Menéndez, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2705-2705
Open Access | Times Cited: 67
Physical Exercise and the Hallmarks of Breast Cancer: A Narrative Review
Celia García‐Chico, Susana López‐Ortiz, Saúl Peñín‐Grandes, et al.
Cancers (2023) Vol. 15, Iss. 1, pp. 324-324
Open Access | Times Cited: 30
Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer
Samson Mathews Samuel, Elizabeth Varghese, Peter Kubatka, et al.
Biomolecules (2019) Vol. 9, Iss. 12, pp. 846-846
Open Access | Times Cited: 73
Hyperglycemia and Chemoresistance in Breast Cancer: From Cellular Mechanisms to Treatment Response
Jie Qiu, Qinghui Zheng, Xuli Meng
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 47
The emerging role of 27-hydroxycholesterol in cancer development and progression: An update
Saade Abdalkareem Jasim, Hamzah H. Kzar, Mohammed Hayder Hamad, et al.
International Immunopharmacology (2022) Vol. 110, pp. 109074-109074
Closed Access | Times Cited: 28
Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review
Yi Zhang, Fang Zhou, Jiaheng Guan, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 250-250
Open Access | Times Cited: 19
High Glucose Represses the Anti-Proliferative and Pro-Apoptotic Effect of Metformin in Triple Negative Breast Cancer Cells
Sharon Varghese, Samson Mathews Samuel, Elizabeth Varghese, et al.
Biomolecules (2019) Vol. 9, Iss. 1, pp. 16-16
Open Access | Times Cited: 53
Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells
Samson Mathews Samuel, Elizabeth Varghese, Lenka Koklesová, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2482-2482
Open Access | Times Cited: 40
Disrupting CISD2 function in cancer cells primarily impacts mitochondrial labile iron levels and triggers TXNIP expression
Ola Karmi, Yang‐Sung Sohn, Sara I. Zandalinas, et al.
Free Radical Biology and Medicine (2021) Vol. 176, pp. 92-104
Open Access | Times Cited: 36
Glucagon-like peptide-1 receptor activation by liraglutide promotes breast cancer through NOX4/ROS/VEGF pathway
Zhanzhao Liu, Xianxian Duan, Mengci Yuan, et al.
Life Sciences (2022) Vol. 294, pp. 120370-120370
Closed Access | Times Cited: 24
The impacts of dipeptidyl- peptidase 4 (DPP-4) inhibitors on common female malignancies: A systematic review
Anoosha Niazmand, Reza Nedaeinia, Nasimeh Vatandoost, et al.
Gene (2024) Vol. 927, pp. 148659-148659
Open Access | Times Cited: 5
Clinical Significance of Elevated S100A8 Expression in Breast Cancer Patients
Dujuan Wang, Guo‐Hong Liu, Balu Wu, et al.
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 39
Impact of diabetes on outcomes in breast reconstruction: A systematic review and meta-analysis
Qinxin Liu, Ayushi Aggarwal, Mengfan Wu, et al.
Journal of Plastic Reconstructive & Aesthetic Surgery (2022) Vol. 75, Iss. 6, pp. 1793-1804
Closed Access | Times Cited: 20
New benzimidazole‐oxadiazole derivatives: Synthesis, α‐glucosidase, α‐amylase activity, and molecular modeling studies as potential antidiabetic agents
Ulviye Acar Çevik, İsmail Çeli̇k, Leyla Paşayeva, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 5
Closed Access | Times Cited: 11
Triglyceride-glucose index and triglyceride-glucose–body mass index as prognostic factors for early stage breast cancer patients receiving neoadjuvant chemotherapy
Fucheng Li, Tian Gao, Zhaoting Li, et al.
Translational Oncology (2025) Vol. 53, pp. 102292-102292
Closed Access
The hidden pathway: biological aging as a mediator between diabetes and breast cancer risk: a Mendelian randomized study
Yong Zhao, Jingzhi Zhang, Dong Chen, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Complexity of insulin resistance in early-onset colorectal cancer
Samson Mathews Samuel, Elizabeth Varghese, Dietrich Büsselberg
Cancer Cell (2025)
Closed Access
Prognostic Model for Breast Cancer Based on Blood Glucose-Related Genes in Different Subtypes
南平 吴
Advances in Applied Mathematics (2025) Vol. 14, Iss. 04, pp. 536-547
Closed Access
Page 1 - Next Page

Scroll to top